Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04793880 · ClinicalTrials.gov registry record · NA
Cost and Shared Decision-Making for Heart Failure
A NA study of Chronic Heart Failure, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 247
- Enrollment target
- 4
- Study locations
NCT04793880: Completed NA study of Chronic Heart Failure, sponsored by Emory University.
NCT04793880 is a NA study of Chronic Heart Failure that has completed, run by Emory University. The registered enrollment target is 247 participants, below the 402-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (39% lower). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04793880, a NA study of Chronic Heart Failure, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 247 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is designed to understand the impact of providing patient-specific cost at the time of the clinical encounter on decision-making for heart failure medications. The researchers will provide patients with heart failure with patient-specific cost information for non-generic heart failure medications. This cost information will be populated onto a checklist of recommended HF medications so that patients and their clinicians will have this information available during their clinical encounter. Patients in the control arm will receive the same checklist but without the cost information.
Primary Outcome
The number of patients whose clinic encounters involved a discussion of heart failure medication cost will be compared between study arms. The discussion of heart failure medication cost is a binary outcome of whether or not the cost of heart failure medication was discussed during the recorded clinical encounter. Any mention of heart failure medication cost will be counted as a cost discussion. The primary outcome will be analyzed using a generalized linear mixed model, with covariates includin
Conditions Studied
Interventions
- BEHAVIORAL Medication Cost Information
- BEHAVIORAL Heart Failure Medicines Checklist
Study Locations (4)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory Clinic, Emory University Hospital - Atlanta
- Emory St. Joseph's Hospital - Atlanta
Colorado
- UCHealth Heart and Vascular Center Clinics - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 247 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2023-11-15 |
| Phase | NA |
What the finished NCT04793880 record still lists
NCT04793880 is an interventional study that assigns participants to a tested intervention. The registered 247 participants enrollment target is mid-sized for trials with a published cap, below the 402-participant average among 12 other Chronic Heart Failure trials with a reported enrollment target (39% lower).
The record links to 1 condition, with Chronic Heart Failure appearing as the primary indexed condition, and to 2 interventions - of which Medication Cost Information is the first listed.
NCT04793880 reports a single indexed study location in Georgia, Colorado.
Frequently Asked Questions
What is clinical trial NCT04793880 about?
NCT04793880 is a clinical study titled "Cost and Shared Decision-Making for Heart Failure". This study is designed to understand the impact of providing patient-specific cost at the time of the clinical encounter on decision-making for heart failure medications. The researchers will provide patients with heart failure with patient-specific cost information for non-generic heart failure med...
What is the current status of trial NCT04793880?
This trial is currently completed. It is a NA study. The enrollment target is 247 participants. The study started on 2021-06-01. Estimated completion is 2023-11-15.
What conditions does trial NCT04793880 study?
This clinical trial studies the following conditions: Chronic Heart Failure.
What interventions are being tested in trial NCT04793880?
The interventions under investigation include: Medication Cost Information (BEHAVIORAL), Heart Failure Medicines Checklist (BEHAVIORAL).
Who is sponsoring clinical trial NCT04793880?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04793880 being conducted?
This trial has 4 study locations across Colorado, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04793880's enrollment target sits among peer trials
247 5th of 12 higher than 8 of 12 other Chronic Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Mindful Steps 2.0: Promoting Physical Activity in Patients With COPD and HF
RECRUITING · NA
-
Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System
RECRUITING · NA
-
Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment
RECRUITING · NA
-
The HEARTFELT Study
RECRUITING · NA
-
Telehealth Management in HF Disparity Patients
COMPLETED · NA
-
Multi-center Trial of Ferric Derisomaltose Versus no Intravenous Iron in Iron-deficient Subjects With Symptomatic Chronic Heart Failure
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04269902 · 247 participants · Phase 3
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
- NCT04989803 · 247 participants · Phase 1
Study of KITE-363 or KITE-753 in Participants With Relapsed and/or Refractory B-cell Lymphoma
- NCT05521399 · 247 participants
Heart Transplantation - Renewal
- NCT05556824 · 247 participants · Phase 2
Multi-Center Study of Panosyl-Isomaltooligosaccharides Adjunctive to PPI Therapy to Treat GERD
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI